Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

We have received FDA 510(k) clearance, which confirms that NaoTrac is substantially equivalent in safety and effectiveness to legally marketed devices in the U.S. This recognition enables us to bring NaoTrac to U.S. hospitals and surgical teams, helping them achieve even higher levels of precision and efficiency in the operating room and save more lives. We have received FDA 510(k) clearance, which confirms that NaoTrac is substantially equivalent in safety and effectiveness to legally marketed...

Taiwan, 17/06/2025 (informazione.news - comunicati stampa - salute e benessere)

We have received FDA 510(k) clearance, which confirms that NaoTrac is substantially equivalent in safety and effectiveness to legally marketed devices in the U.S. This recognition enables us to bring NaoTrac to U.S. hospitals and surgical teams, helping them achieve even higher levels of precision and efficiency in the operating room and save more lives.

NaoTrac combines advanced robotic automation with AI-driven accuracy, aiming to elevate neurosurgical outcomes and improve safety for both surgeons and patients.

This step marks a before-and-after moment for Brain Navi — one that paves the way for broader international adoption. As we move forward, we expect to see more and more NaoTrac systems installed around the world, supporting surgical teams and improving patient care across borders.

Photo - https://mma.prnewswire.com/media/2712635/Jerry_NaoTrac_S_1_1.jpg 
Logo - https://mma.prnewswire.com/media/1873615/5373888/Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/brain-navi-achieves-us-fda-approval-for-neurosurgical-robot-naotrac-302483707.html